Skip to main content

Pasithea Therapeutics Corp. hedge fund holdings

KTTAWNASDAQ
$0.00-0.01 (-74.31%)Delayed · as of Sep 15, 2026

Every quarter, large institutional investment managers with over $100M in U.S.-listed assets under management disclose their U.S. equity holdings through 13F filings. Read together, those filings show which businesses professional capital is moving into and out of.

Price vs funds buying and selling

KTTAW · close · 13FReported Aug 14, 2026

Price vs funds buying and selling data

Showing the 1Y range: Jul 17, 2026 to Sep 15, 2026. Price (-74.3%). 0 fund reports plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Funds buying · new + increased
Funds selling · reduced + closed
Net buyers vs sellers
Buying = new + increased; selling = reduced + closed. Counts exclude position changes under 5% of the fund's holding last quarter.

Price and fund activity data

Quarterly 13F fund buying and selling activity
QuarterFunds buyingFunds sellingBoughtSoldFilersReported
Q2 202512$335$2.22K5Aug 14, 2025
Q3 202510$247$45Nov 14, 2025
Q4 202512$784$4544Feb 14, 2026
Q1 202610$151$05May 15, 2026
Q2 202621$232$1506Aug 14, 2026

Quarterly action breakdown

Q2 2026
6 filers
New position
2
$219+24.7K sh
Increased
0
$13+1.9K sh
Reduced
0
$00 sh
Out / sold
1
-$150-15K sh
Last 4 quarters · free
Reported Aug 14, 2026
FundActionChange in dollarValue% of portfolioReported
No funds in this 13F value range for Q2 2026

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.